- Current report filing (8-K)
June 10 2010 - 12:24PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): June 10, 2010
ROCHESTER MEDICAL
CORPORATION
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
Minnesota
|
|
0-18933
|
|
41-1613227
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
One Rochester Medical Drive,
Stewartville, MN
|
|
55976
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number,
including area code:
(507) 533-9600
|
Not
Applicable
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 7.01. Regulation FD
Disclosure.
The following
information is being “furnished” in accordance with General
Instruction B.2 of Form 8-K and shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities of
that section, nor shall it be deemed to be incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act,
except as expressly set forth by specific reference in such filing.
Furnished herewith as
Exhibit 99.1 and incorporated by reference herein is a copy of a
presentation being made by Rochester Medical Corporation on June 10, 2010
at the Jefferies 2010 Global Life Sciences Conference in New York City.
Item 9.01. Financial Statements
and Exhibits.
(d) Exhibits.
Reference is made to
the Exhibit Index hereto with respect to the exhibits furnished herewith.
The exhibits listed in the Exhibit Index hereto are being
“furnished” in accordance with General Instruction B.2 of Form 8-K
and shall not be deemed “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section, nor shall
it be deemed to be incorporated by reference in any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as expressly set forth by
specific reference in such filing.
2
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, hereunto duly
authorized.
Date: June 10, 2010
ROCHESTER MEDICAL
CORPORATION
By:
/s/ David A.
Jonas
David A. Jonas
Chief
Financial Officer
3
EXHIBIT INDEX
|
|
|
Exhibit
No.
|
|
Description
|
99.1
|
|
Presentation being made by Rochester Medical
Corporation on June 10, 2010 at the Jefferies 2010 Global Life Sciences
Conference in New York City
|
4
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Rochester Medical Corp. (MM) (NASDAQ): 0 recent articles
More News Articles